INC Research Partners with goBalto™ to Further Enhance Clinical Study Startup Solution Will Use goBalto Tracker Platform to Optimize Site Activation and Increase Efficiencies in Study Startup
SAN FRANCISCO, Jan. 8, 2013 /PRNewswire/ -- goBalto, Inc., a developer of new-generation web clinical research solutions, today announced that INC Research, a therapeutically-focused clinical research organization (CRO), has selected goBalto Tracker 2.0 as its global site activation solution. Tracker is a secure, web-based platform that enables study teams to track and manage site activation activities in clinical trials.
"We chose goBalto Tracker as part of our study startup solution because it offers enhanced visibility into the traditionally cumbersome process of activating sites for clinical trials," said Alistair Macdonald, Chief Operating Officer at INC Research. "The system creates efficiencies through streamlined communication among sites, sponsors and CROs. This ultimately drives shorter timelines and cost savings for our customers."
Tracker, goBalto's lead product, is a software-as-a-service (SaaS) application that helps small and large clinical research organizations (CROs), pharmaceutical, and medical device companies track multiple studies and keep managers on the same page during the site activation phase of a study. Configurable workflows allow study managers to implement and benchmark processes globally. The application shows real-time status that study managers can use to find process bottlenecks and optimize resources.
Jae Chung, Founding CEO of goBalto, stated "The clinical trial industry recognizes how important it is to get study startup right and INC Research is at the forefront of utilizing technology to benefit their study sponsors in this critical phase. We're very proud that INC Research has selected Tracker as its study startup solution to provide transparency and insight into the site initiation process."
About INC Research
INC Research is a therapeutically-focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
goBalto develops next-generation, cloud-based solutions that simplify how clinical trials are conducted in the pharmaceutical, biotechnology, and medical device industries. Our flagship product, Tracker, is a purpose-built software-as-a-service clinical research tool. It enables clinical trial sponsors and research organizations to track and collaborate on operational data in a transparent, regulatory-compliant, and user-friendly way. Founded 2008 in Silicon Valley by biotechnology industry veteran Jae Chung, goBalto is backed by leading health technology investors. For more information, visit www.gobalto.com.
SOURCE goBalto, Inc.